| Overview |
| bsm-61840r |
| PSGL-1/CD162 Recombinant Antibody |
| IHC-P, IHC-F, IP, IF, Flow-Cyt, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PSGL 1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 6404 |
| Q14242 |
| CD162; CLA; PSGL1; SELPLG. |
| A SLe(x)-type proteoglycan, which through high affinity, calcium-dependent interactions with E-, P- and L-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture. |
| Application Dilution |
| IHC-P |
WBWB=1:500-2000 |
| IHC-F |
IHC-PIHC-P=1:50-200 |
| IP |
IHC-FIHC-F=1:50-200 |
| IF |
IPIP=1:20-50 |
| Flow-Cyt |
IFIF=1:50-200 |
| ICC/IF |
Flow-CytFlow-Cyt=1ug/Test |